These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 19118524

  • 1. Suppression of interleukin-6-induced C-reactive protein expression by FXR agonists.
    Zhang S, Liu Q, Wang J, Harnish DC.
    Biochem Biophys Res Commun; 2009 Feb 06; 379(2):476-9. PubMed ID: 19118524
    [Abstract] [Full Text] [Related]

  • 2. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P, Hierro L, Jara P, Alvarez L.
    Am J Physiol Gastrointest Liver Physiol; 2009 May 06; 296(5):G1119-29. PubMed ID: 19228886
    [Abstract] [Full Text] [Related]

  • 3. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
    Jiang T, Wang XX, Scherzer P, Wilson P, Tallman J, Takahashi H, Li J, Iwahashi M, Sutherland E, Arend L, Levi M.
    Diabetes; 2007 Oct 06; 56(10):2485-93. PubMed ID: 17660268
    [Abstract] [Full Text] [Related]

  • 4. The farnesoid X receptor induces very low density lipoprotein receptor gene expression.
    Sirvent A, Claudel T, Martin G, Brozek J, Kosykh V, Darteil R, Hum DW, Fruchart JC, Staels B.
    FEBS Lett; 2004 May 21; 566(1-3):173-7. PubMed ID: 15147890
    [Abstract] [Full Text] [Related]

  • 5. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
    Evans MJ, Mahaney PE, Borges-Marcucci L, Lai K, Wang S, Krueger JA, Gardell SJ, Huard C, Martinez R, Vlasuk GP, Harnish DC.
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar 21; 296(3):G543-52. PubMed ID: 19136377
    [Abstract] [Full Text] [Related]

  • 6. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
    Qin P, Borges-Marcucci LA, Evans MJ, Harnish DC.
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug 21; 289(2):G267-73. PubMed ID: 15817812
    [Abstract] [Full Text] [Related]

  • 7. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
    Cariou B.
    Diabetes Metab; 2008 Dec 21; 34(6 Pt 2):685-91. PubMed ID: 19195631
    [Abstract] [Full Text] [Related]

  • 8. The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.
    Swales KE, Korbonits M, Carpenter R, Walsh DT, Warner TD, Bishop-Bailey D.
    Cancer Res; 2006 Oct 15; 66(20):10120-6. PubMed ID: 17047076
    [Abstract] [Full Text] [Related]

  • 9. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
    Mencarelli A, Renga B, Migliorati M, Cipriani S, Distrutti E, Santucci L, Fiorucci S.
    J Immunol; 2009 Nov 15; 183(10):6657-66. PubMed ID: 19880446
    [Abstract] [Full Text] [Related]

  • 10. The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes.
    Murakami T, Walczak R, Caron S, Duhem C, Vidal V, Darteil R, Staels B.
    Biochem J; 2007 Nov 01; 407(3):461-9. PubMed ID: 17655523
    [Abstract] [Full Text] [Related]

  • 11. FXR-mediated regulation of eNOS expression in vascular endothelial cells.
    Li J, Wilson A, Kuruba R, Zhang Q, Gao X, He F, Zhang LM, Pitt BR, Xie W, Li S.
    Cardiovasc Res; 2008 Jan 01; 77(1):169-77. PubMed ID: 18006476
    [Abstract] [Full Text] [Related]

  • 12. FXR, a multipurpose nuclear receptor.
    Lee FY, Lee H, Hubbert ML, Edwards PA, Zhang Y.
    Trends Biochem Sci; 2006 Oct 01; 31(10):572-80. PubMed ID: 16908160
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of bile acids and bile acid receptors in metabolic regulation.
    Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B.
    Physiol Rev; 2009 Jan 01; 89(1):147-91. PubMed ID: 19126757
    [Abstract] [Full Text] [Related]

  • 15. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
    Yang F, Huang X, Yi T, Yen Y, Moore DD, Huang W.
    Cancer Res; 2007 Feb 01; 67(3):863-7. PubMed ID: 17283114
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FXR-deficiency confers increased susceptibility to torpor.
    Cariou B, Bouchaert E, Abdelkarim M, Dumont J, Caron S, Fruchart JC, Burcelin R, Kuipers F, Staels B.
    FEBS Lett; 2007 Nov 13; 581(27):5191-8. PubMed ID: 17950284
    [Abstract] [Full Text] [Related]

  • 18. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium.
    Chignard N, Mergey M, Barbu V, Finzi L, Tiret E, Paul A, Housset C.
    Hepatology; 2005 Sep 13; 42(3):549-57. PubMed ID: 16037943
    [Abstract] [Full Text] [Related]

  • 19. Transient impairment of the adaptive response to fasting in FXR-deficient mice.
    Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk T, Grefhorst A, Bouchaert E, Fruchart JC, Gonzalez FJ, Kuipers F, Staels B.
    FEBS Lett; 2005 Aug 01; 579(19):4076-80. PubMed ID: 16023103
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.